The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Abstract
OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We did not identify high-quality PCOS-specific evidence to answer the question, hence a clinical consensus recommendation was made based on clinical expertise, an international position statement on CVD risk assessment in PCOS 78 and on national guidelines on absolute CVD risk assessment, 46 management of obesity, 54 lipids 77,79 and hypertension 80 for the general population.”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [78]
In the citing paper
“Previous studies have noted that fasting blood glucose level alone appears to lack sensitivity in screening for prediabetes or DM2 in PCOS, with national and international groups recommending screening all women with PCOS with an OGTT. 78,107”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [78]
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Research works printed but not linked: 1
- Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Ayurvedic treatment of polycystic ovary syndrome (PCOS)
Kumar, R., Kumar, D., Garg, V., & Ali, S. S. (2022) · Southeast Asian Journal of Health Professional · doi:10.18231/j.sajhp.2021.002
Role of Surgery in the Management of PCOS: Rationale and Considerations for Bariatric Surgery
Escobar-Morreale, H. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_17
Self-citationRodgers, R., & Hummitzsch, K. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733232135.793546087
Evran, M., Ballı, H. T., Sert, M., & Tetiker, B. (2016) · Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi) · doi:10.17826/cutf.237682
Polycystic Ovary Syndrome: From in utero to Menopause
(2015) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jsafog-7-2-v
Shwana, S., Shrikrishnapalasuriyar, N., Yin, W. L., Vij, M., & Kalhan, A. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.75
Selvanesan, B. C., & Chappell, N. R. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733232135.793546184
Hyperandrogenism: Acne and Hirsutism
Evans, M. B., & Hill, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-17002-2_40-2
(2015) · The American Pharmacists Association eBooks · doi:10.21019/9781582122397.ch3
Role of BMI in PCOS Towards Cardiovascular Risk FactorsPreprint
Arshad, F.-A., Mehmood, R., Kausar, N., Bibi, A., & Khan, M. A. (2020) · Research Square · doi:10.21203/rs.3.rs-52960/v1
Nestler, J. E., & Laganà, A. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_16
Spanel‐Borowski, K. (2010) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-16077-6_7
(2020) · Springer Publishing Company eBooks · doi:10.1891/9780826173270.ap08
A Possible Screening Marker for Cardiovascular Disease in Polycystic Ovary Syndrome
Kim, A. S., & Wild, R. A. (2022) · Journal of Women s Health · doi:10.1089/jwh.2022.0160
Self-citationJafari, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99729-4.00018-1
Androgenisierung: Diagnostik und Therapie – Akne vulgaris, Hirsutismus, female pattern hair loss
Geisthövel, F., Wetzka, B., & Hanjalic-Beck, A. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-47329-0_17-1
Study the effect some of antioxidant in polycystic ovary syndrome women
Sabah, Z., & Hamzah, S. K. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.11387
Song, X., Ge, L., Wang, D., Li, L., Ma, D., Xiu, L., & Song, X. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2114326
Association Of The LH/FSH Ratio With Electrocardiogram Abnormalities In Polycystic Ovarian SyndromePreprint
Wu, L., Zheng, S., Zhao, G., Tian, B., Sun, Y.-C., Tan, Y. C., Tang, X., Qian, X., & Chen, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2141531/v1
Song, Y., Deng, Y. P., Chung, J. P. W., Li, T. C., Wang, C. C., Li, H., Yang, T., Sui, Y., & Tang, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1046361/v2
UNFOLDING THE INFLUENCE OF ENVIRONMENTAL FACTORS ON THE MATURATION OF POLYCYSTIC OVARIAN SYNDROME
DE, S., MUKHERJEE, G., Adhikari, A., DAS, S., DEEPIKA, R., & Dey, A. (2022) · Pollution Research · doi:10.53550/pr.2022.v41i04.010
A MODERN VIEW OF THE POLYCYSTIC OVARIAN SYNDROME
BRAGA, M., Bordea, E. A., Brătilă, E., Marinescu, B., & Carp-Velişcu, A. (2020) · Annals of the Academy of Romanian Scientists Series of Medicine · doi:10.56082/annalsarscimed.2020.1.5
Cardiovascular risk reduction in polycystic ovary syndrome
Shams, P., Ahmed, I., & Samad, Z. Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00027-x
Hu, R., Huang, Y., Liu, Z., Dong, H., Ma, W., Song, K., Xu, X., Wu, X. W., Geng, Y., Li, F., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3060682/v1
Letter to the Editor: Sex hormones and risk of coronary artery disease in women
Harris, K., Peters, S. A. E., Woodward, M., Montarello, N., & Chan, W. P. (. (2023) · Australian Prescriber · doi:10.18773/austprescr.2023.009
Association of kisspeptin in patients with poly cystic ovarian syndrome
Jahan, N., Banu, J., Mahmud, K. F., Ishrat, S., Deeba, F., Begum, N., Anwary, S. A., Akter, S., & Jahan, S. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20232269
The role of ultrasound findings in detecting infertility in patients with polycystic ovary syndrome
Akhoundi, N., Naseri, Z., Siami, A., Hazara, K., & Hazara, S. (2023) · Italian Journal of Gynaecology and Obstetrics · doi:10.36129/jog.2023.138
ปัจจัยที่สัมพันธ์กับคุณภาพชีวิตด้านสุขภาพในสตรีที่มีภาวะถุงน้ำรังไข่หลายใบ
ธีระวุฒิ, ว., & นาวีเจริญ, ร. (2018) · Chula Digiverse · doi:10.58837/chula.the.2018.1001
Polycystic Ovary Syndrome in Pediatric Obesity
Pereira-Eshraghi, C., Al-Rayess, H., Bomberg, E. M., & Cree‐Green, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-37380-0_11
Endocrine Autoimmunity in Association with Female Infertility
Varma, P. R. R., Josephine, J. A. A., Pillai, A. S., P, K. P., Kumar, S. K. S. S., Renjith, R. K. K. R., Parvathy, P. S. S., Surekha, S. V. V., Simi, S. N. N., Sindhu, S. K. K., et al. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44is-1.1183
Esau, D., & Abramson, B. L. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_8
Hussein, R. A., Ali, I. N., & Sayer, S. A. (2023) · Academia Open · doi:10.21070/acopen.8.2023.7830
Directive clinique n° 444 : Hirsutisme : Évaluation et traitement
Elliott, J., Liu, K. E., & Motan, T. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.102273
PATHOGENESIS OF INSULIN RESISTANCE IN POLYCYSTIC OVARIAN SYNDROME
(2023) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets46351
Bafrouei, M. H. B., Khazali, H., Kalantar, S. M., & Khoradmehr, A. (2023) · Galen Medical Journal · doi:10.31661/gmj.v7i.1045
Shivangi, Dwivedi, D. P., Alam, A., Tripathi, P., Verma, N., & Fatima, D. S. (2024) · International Journal of Homoeopathic Sciences · doi:10.33545/26164485.2024.v8.i2a.1119
Polycystic Ovarian Syndrome (PCOS) among young adult women: an anthropological insight
Ghosh, T., Pal, B., Maji, S., & Goswami, M. (2023) · Papers on Anthropology · doi:10.12697/poa.2023.32.2.06
Sex/Gender Differences in Hypertension and Dyslipidemia
Cho, E. J. (2024) · Springer eBooks · doi:10.1007/978-981-97-0130-8_11 · Cited by 1
de Lima, A. V. R., Amantéa, G. F. G., Cardoso, J. M. D. O., Pereira, L. M. D. O., & Silva, D. R. G. (2024) · Revista Contemporânea · doi:10.56083/rcv4n6-107
Motar, B. A. (2017) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/v6i2.10
Polycystic ovary syndrome with a Sertoli-Leydig cell tumor: A case report
Pozo, V. P. D. A., González, M. M., & Ordúñez, L. D. M. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2024.04.028
IMPACTO DA SÍNDROME DOS OVÁRIOS POLICÍSTICOS NA SAÚDE METABÓLICA: UMA REVISÃO ABRANGENTE
Lanzarini, G. M., Parreira, L. N., Angotti, F. S. B., de Oliveira, M. E. C., Lara, G. R., Lara, W. R., Silva, G. M. D. S. D., Mendonça, M. H. C., Gomes, G. S. M., & dos Santos, K. K. D. S. K. (2024) · Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida · doi:10.36692/3ttqzh22
Sandler, C. N., & SHANK, K. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-54281-7_40
Ultrasonographic Evaluation of Fibrocystic Breast Disease in Patients with Polycystic Ovary Syndrome
Selçuki, N. F. T., Özdemir, E. Ü., BAĞCI, K., Kabakcı, M., Uzunlulu, N., & Bahat, P. Y. (2024) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2023-100320
Polycystic ovary syndrome with a Sertoli-Leydig cell tumor: A case report
Pozo, V. P. D. A., González, M. M., & Ordúñez, L. D. M. (2024) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2024.04.025
Chaabouni, K., Saadallah-Kallel, A., Brahim, S. B., Chaabane, K., Frikha, M., Mnif, M. F., Keskes, L., Abdelhedi, F., & Ayadi, F. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40411
Ortiz-Flores, A. E., & Escobar-Morreale, H. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00166-7
Self-citationSex differences in cardiovascular, renal, and metabolic responses to androgens
Cardozo, L. L. Y., Rezq, S., Reckelhoff, J. F., & Romero, D. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22266-5.00001-x
Sindroma e vezores policistike - Shkaku kryesor i infertilitetit
Laho, A. (2024) · Optime · doi:10.55312/op.vi2.4583
Menstrual Disorders and Hyperandrogenism in Adolescence
DiVall, S. A., & Rosenfield, R. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_27
Bashir, K., Ahmad, M., Saif, S., Sharif, M., Niazi, U. K., Shahzadi, R., & Iftikhar, A. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102139 · Cited by 2
Polycystic ovary syndrome: Implications for cardiovascular, endometrial, and breast disease
Escobar-Morreale, H. F., & Catteau-Jonard, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00244-2
Self-citation洪, 雯. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551542
Kaur, H., & Verma, S. K. (2025) · Springer transactions in civil and environmental engineering · doi:10.1007/978-981-96-4047-8_6
Dey, S., Chakraborty, I., Biswas, P., Basak, B., Paul, A., Chakraborty, P., & Haldar, R. (2025) · BLDE University Journal of Health Sciences · doi:10.4103/bjhs.bjhs_26_24
Bondili, S. (2025) · i-manager s Journal on Life Sciences · doi:10.26634/jls.4.1.22112
Al-Shammari, S. M. H. (2023) · International Journal of Advanced Research in Medicine · doi:10.22271/27069567.2023.v5.i2b.651
CLINICAL PROFILE AND OUTCOMES OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
Poonia, M. (2025) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555/6vtsz040
Gestörte Metabolik und kardiovaskuläres Risiko am Beispiel des polyzystischen Ovarialsyndroms (PCOS)
Arjune, S., & Hanßen, R. (2025) · Aktuelle Kardiologie · doi:10.1055/a-2606-7002
Li, B., Li, S., Duan, Z., Yu, H., Zhou, Y., & Lin, X. (2025) · Medicine · doi:10.1097/md.0000000000044965 · Cited by 1
Polymeric Microspheres for Sustained Delivery of Rutin in the Management of PCOS
Roy, M., Mazumder, R., Singh, N., Dogra, A., & Mishra, R. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10181-7
Feng, T., Wang, Q. L., Shen, F., & Yang, J. (2025) · International Journal of Endocrinology · doi:10.1155/ije/8861740
Sultana, A., Begum, K., Shirin, M. T., Kabir, R., Jesun, A. F., & Tahsin, F. (2024) · TAJ Journal of Teachers Association · doi:10.70818/taj.v037i02.0497
Sulu, C., Pervaz, I., Gürer, T., Yildiz, D., Tas, A. C., Demir, A. N., Şahin, S., Özkaya, H. M., Konukoğlu, D., Tüten, A., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1722978 · Cited by 1
Oxidative Stress and Inflammatory Status in PCOS
Sriwastva, M. K., & Srivastava, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010019
Loucks, T. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Harris, K., Peters, S. A. E., & Woodward, M. (2024) · Figshare · doi:10.6084/m9.figshare.26618551
Chen, S., Guo, Z., & Yu, Q. (2023) · Figshare · doi:10.6084/m9.figshare.24558172
Chen, S., Guo, Z., & Yu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.24558199
Particularités de l’infarctus du myocarde chez la femme
Deloziere, C., Vidal‐Petiot, E., & Courand, P. (2025) · médecine/sciences · doi:10.1051/medsci/2025225
Farland, L. V., Degnan, W. J., Wang, S., Gaskins, A. J., Chavarro, J. E., Rich-Edwards, J. W., & Missmer, S. A. (2026) · Journal of Women s Health · doi:10.1177/15409996251414608
Dumont, T., Peeva, M., & Masri, M. E. (2026) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2026.102702
Tonato, E. A. J., Rea, A. M. C., Gavilanes, A. M. C., & Barahona, A. S. C. (2026) · Esprint Investigación · doi:10.61347/ei.v5i1.256
Fayyaz, L., Ashfaq, O., Saleem, M., Khan, A. A., & Ali, F. (2025) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v5i5.1792
Diagnostic and predictive biomarkers of polycystic ovary syndrome in Nigeria: a mini-review
Suleiman, H. A., & Ayodeji, A. S. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00315-3
Reproductive Outcomes After In Vitro Fertilisation Amongst Different Phenotypes of PCOS
Udhwani, R. S., Satwik, R., Majumdar, A., Gupta, S., Tiwari, N., Nayar, S., & Shekhar, B. (2026) · Fertility Science and Research · doi:10.25259/fsr_43_2025
Metabolic aspects of polycystic ovary syndrome
Pappas, D., Kandaraki, E., Kalogirou, A., & Diamanti‐Kandarakis, E. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2656240
Self-citationOvarian intelligence: AI applications leveraging AMH and inhibin B
Xu, H., Bischoff, F., Wang, Q., & Li, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1724929
Abordagem da dislipidemia na síndrome dos ovários policísticos
Costa, L. O. B. F., & Soares, G. M. (2021) · Femina · doi:10.61622/0100-7254499202102
Yan, M., & Shao, L. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1820967
Bass, I. R., Nosova, E. V., & Dunaif, A. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00085-8
BMI-dependent methylation and clinical signatures in North Indian women with PCOS
Rawat, K., Sandhu, A., Kumar, A., Saha, L., Walia, R., Saha, P. K., & Bhatia, A. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_2980_2025
Carmina, E., & Longo, R. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135165
Self-citationLee, D., Hwang, K. R., Kim, S., Choi, Y. M., & Kim, J. (2026) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2026.105863
Yılmaz, K. İ. A., Yılmaz, E., & Çamcı, S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135273
Zehra, F., Ali, S., Rather, F., & Mir, R. A. (2026) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v16i7.7874
Güneş, A., & Gülücü, S. (2026) · Journal of Ophthalmology · doi:10.1155/joph/1313399
Huang, X., Chen, Z., Zhang, L., & Li, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797826
Milinković, M., Matic, A., Jakovljevic, V. L., Jovic, N., Novakovic, S., Todorović, T., Milosavljević, J., Pindović, B., Sretenovic, J. Z., Canovic, P., et al. (2026) · Pathophysiology · doi:10.3390/pathophysiology33030061
Sienicka, M., Winiarska, W., Bełcikowska-Skowron, W. R., Siegmund, A., Chrapczyńska, M., Filarecka, A., Przybyszewski, P., Przybyszewska, E., Gatniejewska, J., & Prudzic, P. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.5856
Distúrbios do metabolismo dos hidratos de carbono na síndrome dos ovários policísticos
Barcellos, C. R. G. (2019) · Femina · doi:10.61622/0100-7254478201907
Monroe, M. N., Curylo, A. L., Amirkhosravi, F., Huitron, E. I. G., Ezeokeke, G. I., Ojediran, I. G., Wang, J. K., Cremer, S. E., & Grande-Allen, K. J. (2026) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-026-00859-5
BURGUCU, H. Ç., Kaya, E. Y., Yümlü, A., Korkmaz, M., Bayman, M. G., & Aksu, O. (2026) · Anatolian Current Medical Journal · doi:10.38053/acmj.1974306
Metadata
- Authors
- Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
- Affiliations
- OU Health (US)
- University of Palermo (IT)
- University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
- University of Pennsylvania (US)
- Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
- Icahn School of Medicine at Mount Sinai (US)
- Columbia University (R.L.), New York, New York 10027
- The University of Adelaide (AU)
- University of Pittsburgh (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Carmina, Enrico
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-05-01
- Volume
- 95
- Issue
- 5
- Pages
- 2038-2049
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2105749473
- Semantic Scholar
- 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
- Cited by
- 1,010
- References
- 146
- Citations by year
- 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
- FWCI
- 79.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
